RDLworks to provide the most helpful studies and research for health care professionals.

  • Shen G, Metzger A, Wallace D*, Correia P, and Morris R
    Anti-C1q specific IgG antibodies in SLE patients and other disease groups
    Arthritis Rheum. 2004; 50 (supplement): S600 –S601.
  • Wu R, Owen GC, Liu T, Shen G and Morris R
    Significance of the detection of HIV-1 gag- and /or pol-CD8/A2 T-lymphocytes in HIV-patients
    Immunology Letters. 2005; 98: 73-81.
  • Wu R, Shen GQ, Morris R, Patnaik M, and Peter JB
    Elevated autoantibodies against oxidized palmitoyl arachidonoyl phosphocholine in patients with hypertension and cardial infarction
    J Autoimmunity. 2005; 15: 1-8.
  • Shen G and Morris R et al
    RNA polymerase I/III autoantibodies in System Sclerosis and different disease groups
    Clinical Chemistry. 2005; 51 (6 suppl): A89
  • Shen G, Morris R, Wallace D, Correia P, Lehrhoff  L, and Metzger A
    Anti-alpha-fodrin specific IgA antibodies in Sjogren’s Syndrome (SS) and other autoimmune diseases
    Clinical Chemistry. 2005; 51 (6 suppl): A121.
  • Lienesch DW, Sherman KE, Metzger A, and Shen
    Anti-C1q antibodies in patients with chronic hepatic C infection
    Arthritis Rheum. Submitted.
  • Wu R, Shen GQ, Morris R, Patnaik M, Peter JB
    Elevated Levels of Autoantibodies against oxidized palmitoyl arachidonoyl phosphocholine (oxPAPC) in patients with hypertension and myocardial infarction
    J Autoimmunity. 2005;24:349-56.
  • Lienesch DW, Sherman KE, Metzger A and Shen GQ
    Anti-C1q antibodies in patients with chronic hepatitis C Infection
    Clin Exp Rheumatol. 2006; 24: 183-5.
  • Shen GQ, Song Y, Metzger A, Correia P and Morris R
    Anti-neuronal antibodies in CNS-SLE patients and other autoimmune diseases
    Arthritis Rheumatism 2006; 54: S292.
  • Kang EH, GQ Shen, Morris R, Metzger A, Lee EY, Song YW
    Flow cytometric assessment of anti-neuronal antibodies in central nervous system involvement of systemic lupus erythematosus and other autoimmune diseases
    Lupus. 2008; 17:21-25.
  • In-house study comparing the ability of newer generation anti-dsDNA ELISA assays to follow SLE disease activity relative to the Farr Assay.
  • Shen, G, et al
    “RNA polymerase I/III autoantibodies in systemic sclerosis and different disease groups”
    Clinical Chemistry, Vol. 51, No. 6 (Supplement), A89, 2005.
  • Shen, G, et al
    “Anti-alpha-fodrin specific IgA antibodies in Sjogren’s Syndrome and other autoimmune diseases”
    Clinical Chemistry, Vol. 51, No. 6 (Supplement), A121, 2005.
  • Wu, R, et al
    “Elevated levels of autoantibodies against oxidized palmitoyl arachidonoyl phosphocholine (oxPAPC) in patients with hypertension and myocardial infarction”
    J Autoimmunity, Vol. 24, 349-56, 2005.
  • In-house study comparing the sensitivity and specificity of the third generation versus second generation anti-ccp assay in 540 Rheumatoid Arthritis, autoimmune disease group and normal control samples from our serum bank.
  • Hueber W, et al
    “Proteomic analysis of secreted proteins in early rheumatoid arthritis: Anti-citrulline reactivity is associated with upregulation of proinflammatory cytokines,”
    Ann Rheum Dis published online 10 Aug 2006.
  • In-house study utilizing 1500 patient samples from our serum bank to compare the clinical utility of the commercially available bead-based autoimmune multiplex assays versus established methods (IFA, RIA and ELISA).
  • Shen, GQ, et al
    “Anti-neuronal antibodies in CNS-SLE patients and other autoimmune diseases”
    Arthritis & Rheumatism, Vol. 54, No. 9 (Supplement), S292-3, 2006.
  • Ishimori, ML, et al
    “Screening for autoantibodies: the significance of ANA titer and its relationship to other autoantibodies”
    Arthritis & Rheumatism, Vol. 54, No. 9 (Supplement), S441-2, 2006.